RaySearch Laboratories AB (publ) (RSLBF)
USD 19.09
(0.0%)
USD 19.09
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 45 Million | 34.07 Million | 29.14 Million | 40.36 Million | 34.19 Million | 20.13 Million |
| Net Income | 8.05 Million | 2.27 Million | -5.2 Million | -1.1 Million | 5.38 Million | 8.85 Million |
| Depreciation & Amortization | 28.24 Million | 28.36 Million | 250 Million | 9.32 Million | 7.35 Million | 2.05 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 6.05 Million | 4.02 Million | 9.14 Million | 16.06 Million | 9.01 Million | 4.19 Million |
| Other non-cash items | 53.07 Million | -583.5 Thousand | -224.78 Million | 16.08 Million | 12.44 Million | 4.94 Million |
| Investing Cash Flow | -20.66 Million | -22.1 Million | -28.02 Million | -27.46 Million | -22.65 Million | -25.22 Million |
| Investments in PPE | -20.66 Million | -22.1 Million | -255.22 Million | -27.46 Million | -22.65 Million | -25.22 Million |
| Acquisitions | - | - | - | - | - | 1015.13 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -18.34 Million | -18.01 Million | 227.19 Million | -23.81 Million | -17.59 Million | -16.96 Million |
| Financing Cash Flow | -5.56 Million | -7.49 Million | -9.09 Million | -5.36 Million | -11.9 Million | 5.29 Million |
| Debt repayment | -5.58 Million | -2.03 Million | -49.65 Million | -5.35 Million | -8.01 Million | -5.29 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -56.35 Million | -5.46 Million | 40.55 Million | - | -3.89 Million | -1.00 |
| Accounts receivables | 3.13 Million | -6.3 Million | 2.97 Million | 6.35 Million | 4.84 Million | -2.29 Million |
| Accounts payables | 2.92 Million | 10.32 Million | 6.16 Million | 9.71 Million | 4.17 Million | 6.48 Million |
| Inventory | - | - | - | 1.00 | - | - |
| Other working capital | 2.93 Million | 10.36 Million | 3.92 Million | - | 1.00 | 6.48 Million |
| Cash at beginning of period | 15.3 Million | 11.28 Million | 20.54 Million | 12.16 Million | 12.65 Million | 12.72 Million |
| Cash at end of period | 33.92 Million | 15.3 Million | 11.28 Million | 20.54 Million | 12.16 Million | 12.65 Million |
| Capital Expenditure | -20.66 Million | -22.1 Million | -255.22 Million | -27.46 Million | -22.65 Million | -25.22 Million |
| Effect of forex changes on cash | -6.83 Million | 10.94 Million | 5.49 Million | -7 Million | 5.04 Million | 6.23 Million |
| Net cash flow / Change in cash | 18.61 Million | 4.01 Million | -9.25 Million | 8.38 Million | -492.12 Thousand | -66.26 Thousand |
| Free Cash Flow | 24.33 Million | 11.96 Million | -226.07 Million | 12.89 Million | 11.54 Million | -5.09 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.76 Million | 3.42 Million | 3.11 Million | 8.05 Million | 1.96 Million | 1 Million |
| Depreciation & Amortization | - | 6.82 Million | 7.43 Million | 28.24 Million | 2.57 Million | 6.3 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 688.38 Thousand | 6.89 Million | -919.88 Thousand | 6.05 Million | 1.15 Million | -147.67 Thousand |
| Other non-cash items | 7.36 Million | 5.22 Million | 17.58 Million | 53.07 Million | 5.18 Million | -728.98 Thousand |
| Investing Cash Flow | -5.44 Million | -5.67 Million | -6.37 Million | -20.66 Million | -3.3 Million | -5.35 Million |
| Investments in PPE | -5.44 Million | -5.67 Million | -6.37 Million | -20.66 Million | -3.3 Million | -8.68 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -54.63 Million | -4.68 Million | -5.66 Million | -18.34 Million | -3.18 Million | 3.33 Million |
| Financing Cash Flow | -9.47 Million | -1.74 Million | -558.93 Thousand | -5.56 Million | -1.77 Million | -1.38 Million |
| Debt repayment | - | -1.74 Million | -561.57 Thousand | -5.58 Million | -1.57 Million | -1.3 Million |
| Dividends payments | -6.43 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.03 Million | - | - | - | - | - |
| Accounts receivables | -1.62 Million | 1.08 Million | -2.02 Million | 3.13 Million | 1.84 Million | -1.66 Million |
| Accounts payables | 2.31 Million | 5.81 Million | 1.1 Million | 2.92 Million | -689.56 Thousand | 1.51 Million |
| Inventory | - | - | - | - | - | 1.00 |
| Other working capital | 24.66 Million | 5.83 Million | 1.11 Million | 2.93 Million | -121.73 Thousand | - |
| Cash at beginning of period | 41.1 Million | 33.92 Million | 27.96 Million | 15.3 Million | 22.72 Million | 23.37 Million |
| Cash at end of period | 40.86 Million | 41.1 Million | 33.92 Million | 33.92 Million | 27.96 Million | 22.72 Million |
| Capital Expenditure | -5.44 Million | -5.67 Million | -6.37 Million | -20.66 Million | -3.3 Million | -8.68 Million |
| Effect of forex changes on cash | -686 Thousand | 8.59 Million | -8.47 Million | -6.83 Million | -3.13 Million | 5.79 Million |
| Net cash flow / Change in cash | -243.14 Thousand | 7.18 Million | 5.95 Million | 18.61 Million | 5.23 Million | -645.8 Thousand |
| Free Cash Flow | 9.07 Million | 9.94 Million | 5.05 Million | 24.33 Million | 7.57 Million | -2.24 Million |
CSCHF
PTAUY
APTUS
1480
STC
HXPLF